TAD-600 600 mg Biomedica Foscama

Description

TAD-600 600 mg Biomedica Foscama — This Biomedica Foscama formulation delivers this pharmaceutical-grade injectable compound is formulated for optimal bioavailability through intramuscular or subcutaneous administration. It provides steady blood levels for consistent anabolic activity, enhanced protein synthesis, and accelerated recovery. This formulation is dosed at 600 mg per unit.

Key Benefits

• N-acetylcysteine — glutathione precursor, broad antioxidant support
• Liver and kidney protection on AAS cycles
• Also used for respiratory health and neurological support
• 1200 mg/day standard cycle support
• Inexpensive — standard OTC supplement in many regions
• Each unit dosed at 600 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 600–1200 mg/day on-cycle, split AM/PM. Continue 4 weeks post-cycle.

Manufacturer Notes

Biomedica Foscama is an independent producer in the research-compound market. Before first use, request the batch-specific Certificate of Analysis and confirm the vial’s tamper-evident seal is intact.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.